Concord Medical Services (CCM) Competitors $5.08 -0.17 (-3.14%) Closing price 10/24/2025 03:55 PM EasternExtended Trading$5.04 -0.04 (-0.88%) As of 10/24/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CCM vs. BNR, CORBF, PIII, ATPC, BDSX, BMGL, MGRX, MRAI, BRTX, and BGLCShould you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include Burning Rock Biotech (BNR), Global Cord Blood (CORBF), P3 Health Partners (PIII), Agape ATP (ATPC), Biodesix (BDSX), Basel Medical Group (BMGL), Mangoceuticals (MGRX), Marpai (MRAI), Biorestorative Therapies (BRTX), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. Concord Medical Services vs. Its Competitors Burning Rock Biotech Global Cord Blood P3 Health Partners Agape ATP Biodesix Basel Medical Group Mangoceuticals Marpai Biorestorative Therapies BioNexus Gene Lab Concord Medical Services (NYSE:CCM) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings. Does the media prefer CCM or BNR? In the previous week, Burning Rock Biotech had 2 more articles in the media than Concord Medical Services. MarketBeat recorded 3 mentions for Burning Rock Biotech and 1 mentions for Concord Medical Services. Burning Rock Biotech's average media sentiment score of 0.83 beat Concord Medical Services' score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the news media. Company Overall Sentiment Concord Medical Services Neutral Burning Rock Biotech Positive Is CCM or BNR more profitable? Concord Medical Services has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -26.04%. Concord Medical Services' return on equity of 0.00% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A Burning Rock Biotech -26.04%-23.61%-15.73% Which has better valuation & earnings, CCM or BNR? Concord Medical Services has higher earnings, but lower revenue than Burning Rock Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$52.60M0.42-$42.23MN/AN/ABurning Rock Biotech$70.67M1.99-$47.49M-$1.90-6.87 Do analysts rate CCM or BNR? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals & insiders hold more shares of CCM or BNR? 30.0% of Burning Rock Biotech shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, CCM or BNR? Concord Medical Services has a beta of -1.04, suggesting that its share price is 204% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. SummaryBurning Rock Biotech beats Concord Medical Services on 6 of the 11 factors compared between the two stocks. Get Concord Medical Services News Delivered to You Automatically Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CCM vs. The Competition Export to ExcelMetricConcord Medical ServicesMED IndustryMedical SectorNYSE ExchangeMarket Cap$22.10M$3.68B$6.22B$22.11BDividend YieldN/A1.11%5.72%3.55%P/E RatioN/A13.0131.5033.37Price / Sales0.421.26594.9261.75Price / CashN/A17.7337.2524.64Price / Book0.104.0112.054.66Net Income-$42.23M$38.94M$3.34B$1.02B7 Day Performance-6.27%-0.48%1.93%2.22%1 Month Performance-19.29%-1.02%7.77%2.07%1 Year Performance-33.62%10.72%56.40%14.05% Concord Medical Services Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCMConcord Medical Services0.3296 of 5 stars$5.09-3.1%N/A-34.1%$22.10M$52.60M0.00970Analyst ForecastGap DownBNRBurning Rock Biotech0.8495 of 5 stars$8.49-1.2%N/A+358.2%$91.35M$70.67M-4.471,390News CoverageAnalyst ForecastGap UpCORBFGlobal Cord BloodN/A$0.75flatN/A-40.0%$91.16M$196.12M0.001,200PIIIP3 Health Partners3.0201 of 5 stars$8.99+3.9%$16.25+80.8%-59.8%$64.63M$1.50B-0.20500Analyst ForecastATPCAgape ATP0.5444 of 5 stars$1.22-0.8%N/A-18.7%$61.01M$1.32M-2.9840News CoverageAnalyst ForecastGap DownBDSXBiodesix3.5784 of 5 stars$7.79+5.3%$32.50+317.2%-79.4%$57.10M$71.32M-1.34220Analyst ForecastBMGLBasel Medical GroupN/A$1.57+3.3%N/AN/A$28.97MN/A0.0036Analyst ForecastMGRXMangoceuticals1.9723 of 5 stars$2.62+3.6%N/A-5.3%$27.62M$620K-0.683MRAIMarpaiN/A$1.47+11.4%N/A+195.0%$26.91M$34.87M-0.56150BRTXBiorestorative Therapies1.539 of 5 stars$1.61+0.6%N/A-0.6%$12.85M$400K-1.277Analyst ForecastBGLCBioNexus Gene Lab0.5187 of 5 stars$5.05-5.4%N/A+30.9%$9.09M$9.51M0.0030News CoverageGap Down Related Companies and Tools Related Companies BNR Alternatives CORBF Alternatives PIII Alternatives ATPC Alternatives BDSX Alternatives BMGL Alternatives MGRX Alternatives MRAI Alternatives BRTX Alternatives BGLC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CCM) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Concord Medical Services Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Concord Medical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.